Market revenue in 2023 | USD 1,960.1 million |
Market revenue in 2030 | USD 2,893.0 million |
Growth rate | 5.7% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.46% in 2023. Horizon Databook has segmented the North America diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the diabetic foot ulcer treatment market in 2022 with the largest market share of 38.73% and is expected to maintain its dominance during the forecast period. Major factors contributing to the growth of this region include increasing geriatric population, growing burden of diabetes due to lifestyle changes, increasing prevalence of obesity, and high cost of treatment.
For instance, as per National Institute of Diabetes and Digestive Kidney Diseases, an estimated 34.2 million people have diabetes, accounting for 10.5% of the U.S. population. In addition, 88 million adults aged 18 years & older have prediabetes, which may further increase the prevalence of chronic diseases in this region.
Similarly, availability of skilled professionals, improvement in healthcare infrastructure, and presence of major market players are expected to drive the market over the forecast period. According to American Diabetes Association, in 2021, the North America and Caribbean Region had the highest expenditure for diabetes of around USD 415 billion, which accounted for around 43% of global expenditure.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America diabetic foot ulcer treatment market , including forecasts for subscribers. This continent databook contains high-level insights into North America diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account